Antidepressant medications and other treatments of depressive disorders:: a CINP Task Force report based on a review of evidence

被引:50
作者
Baghai, Thomas C. [1 ]
Baldwin, David S. [3 ]
Barrett, Barbara [4 ]
Baumann, Pierre [9 ]
Ghalib, Kareem [10 ,11 ]
Goodwin, Guy [6 ]
Grunze, Heinz [1 ,2 ]
Knapp, Martin [4 ]
Leonard, Brian E. [7 ]
Markowitz, John C. [10 ,11 ]
Padberg, Frank [1 ]
Pinder, Roger [8 ]
Sartorius, Norman
Brand, Ursula [5 ]
Fink, Max [12 ]
Furukawa, Toshiaki A. [13 ]
Fountoulakis, Konstantinos N. [14 ]
Jensen, Peter [10 ,11 ]
Kanba, Shigenobu
Riecher-Roessler, Anita [15 ]
机构
[1] Univ Munich, Dept Psychiat & Psychotherapy, D-80336 Munich, Germany
[2] Newcastle Univ, Royal Victoria Infirm, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[3] Royal S Hants Hosp, Univ Dept Psychiat, Southampton SO14 0YG, Hants, England
[4] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England
[5] European Federat Assoc Families Mentally III Peop, D-78462 Constance, Germany
[6] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OC3 7JX, England
[7] Natl Univ Ireland, Galway, Ireland
[8] Pharma Consultant, Shertogenbosch, Netherlands
[9] Univ Dept Psychiat, CH-1008 Prilly, Switzerland
[10] Columbia Univ, New York Presbyterian Hosp, New York, NY 10021 USA
[11] Cornell Univ, New York Presbyterian Hosp, New York, NY 10021 USA
[12] SUNY Stony Brook, Sch Med, Dept Psychiat, New York, NY USA
[13] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi 4678601, Japan
[14] Aristotle Univ Thessaloniki, Dept Psychiat 3, Thessaloniki, Greece
[15] Univ Basel Hosp, Psychiat Poliklin, CH-4031 Basel, Switzerland
关键词
D O I
10.1017/S1461145707008255
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:S1 / S121
页数:121
相关论文
共 161 条
[31]  
Anand A., Malison R.T., McDougle C.J., Price L.H., Antiglucocorticoid treatment of refractory depression with ketoconazole: A case report, Biological Psychiatry, 37, pp. 338-340, (1995)
[32]  
Ananth J., Treatment-resistant depression, Psychotherapy and Psychosomatics, 67, pp. 61-70, (1998)
[33]  
Anderson I.M., SSRIS versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability, Depression & Anxiety, 7, SUPPL. 1, (1998)
[34]  
Anderson I.M., Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability, Journal of Affective Disorders, 58, pp. 19-36, (2000)
[35]  
Anderson C.S., Hackett M.L., House A.O., Interventions for preventing depression after stroke, Cochrane Database of Systematic Reviews, (2004)
[36]  
Anderson I.M., SSRIS versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability, Depression and Anxiety, 7, SUPPL. 1, pp. 11-17, (1998)
[37]  
Anderson I.M., Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability, Journal of Affective Disorders, 58, pp. 19-36, (2000)
[38]  
Anderson I.M., Nutt D.J., Deakin J.F., Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology, Journal of Psychopharmacology, 14, pp. 3-20, (2000)
[39]  
Anderson J., On variability of effects for a metaanalysis of rheumatoid arthritis radiographic progression, Journal of Rheumatology, 27, pp. 540-542, (2000)
[40]  
Andersson H.I., Ejlertsson G., Leden I., Rosenberg C., Chronic pain in a geographically defined general population: Studies of differences in age, gender, social class, and pain localization, Clinical Journal of Pain, 9, pp. 174-182, (1993)